| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9750711 | SUN PHARM | Low dose oral pharmaceutical composition of isotretinoin |
May, 2035
(11 years from now) | |
| US9700535 | SUN PHARM | Oral pharmaceutical composition of isotretinoin |
Aug, 2035
(11 years from now) | |
Absorica Ld is owned by Sun Pharm.
Absorica Ld contains Isotretinoin.
Absorica Ld has a total of 2 drug patents out of which 0 drug patents have expired.
Absorica Ld was authorised for market use on 05 November, 2019.
Absorica Ld is available in capsule;oral dosage forms.
The generics of Absorica Ld are possible to be released after 04 August, 2035.
Drugs and Companies using ISOTRETINOIN ingredient
Market Authorisation Date: 05 November, 2019
Treatment: NA
Dosage: CAPSULE;ORAL
More Information on Dosage
ABSORICA LD family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic